MEDTRONIC HEART VALVES DIVISION EVOLUT PRO TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
|
Back to Search Results |
|
Model Number EVOLUTPRO-26 |
Device Problems
Fluid/Blood Leak (1250); Patient Device Interaction Problem (4001)
|
Patient Problems
Chest Pain (1776); Non specific EKG/ECG Changes (1817); Aortic Valve Insufficiency/ Regurgitation (4450)
|
Event Date 10/31/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
Continuation of d10: product id envpro-16; product lot/serial number (b)(6); product type: delivery catheter system; implant date na; explant date na product id l-envpro-16; product lot/serial number (b)(6); product type: compression loading system; implant date na; explant date na h6.The codes present in section h6 correspond to multiple components/products that comprise this reported event.Select patient information cannot be documented in the report due to regional privacy regulations.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Medtronic received information that following the implant of this transcatheter bioprosthetic valve, aortography identified an unspecified trace aortic regurgitation (ar).Two days later first degree atrio-ventricular (av) block was observed.The heart rate ranged between 60-90 beats per minute.No treatment was required.Eight days post implant, the patient complained of non-specific chest pain.A transthoracic echocardiogram (tte) and laboratory testing was performed but nothing was identified that could explain the chest pain.However, an electrocardiogram (ecg) identified a new left bundle branch block (lbbb).Per the physician, the lbbb did not cause or contribute to the chest pain.No treatment provided for the chest pain.Ultimately, the pain resolved.The patient required hospitalization overnight for surveillance and discharged the next day.No additional adverse patient effects were reported.
|
|
Search Alerts/Recalls
|
|
|